Viewing StudyNCT00246272



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00246272
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2005-10-28

Brief Title: An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
Sponsor: Janssen-Ortho Inc Canada
Organization: Janssen-Ortho Inc Canada

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-10
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2006-05
Completion Date Type: ACTUAL
First Submit Date: 2005-10-28
First Submit QC Date: October 28 2005
Study First Post Date: 2005-10-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-04-26
Last Update Post Date: 2010-04-27
Last Update Post Date Type: ESTIMATED